Brief: Hofseth Biocare Says Atlantic Sapphire And Co Sign LOI To Establish Joint Venture In Miami, U.S.
Nov 1 (Reuters) - Hofseth Biocare Asa HOFBC.OL :
* ATLANTIC SAPPHIRE AS AND HOFSETH BIOCARE ASA SIGN LOI TO
ESTABLISH A JOINT VENTURE IN MIAMI, US
* HBC - ATLANTIC SAPPHIRE, CO AIM TO ENTER INTO DEFINITIVE
AGREEMENT IN Q1 2020, BEGIN LIMITED PRODUCTION IN Q4, 2020
* ATLANTIC SAPPHIRE AND HBC AIMS TO INCREASE OUTPUT ONCE
ATLANTIC
SAPPHIRE BEGINS 20,000T (HOG) ANNUAL PRODUCTION
Source text for Eikon: ID:nGNE2V4GgX
Further company coverage: HOFBC.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering